The small-molecule compound BM-1197 inhibits the antiapoptotic regulators Bcl-2/Bcl-xL and triggers apoptotic cell death in human colorectal cancer cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The small-molecule compound BM-1197 inhibits the antiapoptotic regulators Bcl-2/Bcl-xL and triggers apoptotic cell death in human colorectal cancer cells
Authors
Keywords
BM-1197, BH3 mimetic, Colorectal cancer, Apoptosis, Bcl-2
Journal
TUMOR BIOLOGY
Volume 36, Issue 5, Pages 3447-3455
Publisher
Springer Nature
Online
2014-12-27
DOI
10.1007/s13277-014-2980-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
- (2014) Christos Kontos et al. Anti-Cancer Agents in Medicinal Chemistry
- Colorectal cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- BM-1197: A Novel and Specific Bcl-2/Bcl-xL Inhibitor Inducing Complete and Long-Lasting Tumor Regression In Vivo
- (2014) Longchuan Bai et al. PLoS One
- Colorectal cancer
- (2013) Hermann Brenner et al. LANCET
- BH3 Mimetics: Status of the Field and New Developments
- (2013) C. Billard MOLECULAR CANCER THERAPEUTICS
- Molecular Interactions of Prodiginines with the BH3 Domain of Anti-Apoptotic Bcl-2 Family Members
- (2013) Ali Hosseini et al. PLoS One
- Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells
- (2012) D. Merino et al. BLOOD
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer
- (2012) Jose J. G. Marin et al. DRUG METABOLISM REVIEWS
- Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B
- (2012) R W Rooswinkel et al. Cell Death & Disease
- Prognostic significance of Bcl-xL gene expression in human colorectal cancer
- (2011) Yang Jin-Song et al. ACTA HISTOCHEMICA
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
- (2011) Francesco Crea et al. DRUG RESISTANCE UPDATES
- Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak
- (2011) C Wang et al. ONCOGENE
- BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program
- (2010) D. Ren et al. SCIENCE
- Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members
- (2009) Tristan Gallenne et al. JOURNAL OF CELL BIOLOGY
- Predictive factors of early relapse in UICC stage IâIII colorectal cancer patients after curative resection
- (2009) Hsiang-Lin Tsai et al. JOURNAL OF SURGICAL ONCOLOGY
- Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer
- (2008) C. L. Hann et al. CANCER RESEARCH
- Induction of Noxa Sensitizes Human Colorectal Cancer Cells Expressing Mcl-1 to the Small-Molecule Bcl-2/Bcl-xL Inhibitor, ABT-737
- (2008) K. Okumura et al. CLINICAL CANCER RESEARCH
- ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts
- (2008) Zhe-Yu Hu et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search